Trimetazidine Dihydrochloride Modified Release 35 mg Tablets are a specialized medication used to manage angina pectoris and other heart conditions. Trimetazidine works by optimizing cellular metabolism in the heart muscle, improving efficiency and reducing the frequency and severity of angina attacks. This therapy helps patients maintain a better quality of life and supports cardiovascular health.
Trimetazidine Dihydrochloride (35 mg): A metabolic agent that enhances myocardial glucose utilization by inhibiting fatty acid oxidation. This preserves cellular function and improves cardiac performance under stress.
Take Trimetazidine 35 mg MR Tablets exactly as prescribed by your doctor. Swallow the tablet whole, preferably with water, and follow your doctor’s advice regarding timing and dosage. Do not crush or chew the modified-release tablet.
May include nausea, dizziness, headache, or mild gastrointestinal discomfort. Consult your doctor if any side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Trimetazidine Dihydrochloride 35 mg MR sourced from reputed pharmaceutical manufacturers. Flavdey – MR 35 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.